News Focus
News Focus
icon url

kamehameha

02/23/12 8:59 AM

#137660 RE: hptaxis #137658

looks promising, good chances for an all-oral treatment, GILD needs to look out for alternatives to VRUS compounds.
icon url

DewDiligence

02/23/12 10:46 AM

#137669 RE: hptaxis #137658

Quiz: In what way does VRTX’s newly announced phase-2b study differ from nearly every HCV study VRTX has conducted during the past few years?